Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)

Clinical trial NCT02085798 · COMPLETED

Trial details

NCT number: NCT02085798
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Myelodysplastic Syndrome Leukemia, Myelomonocytic, Chronic

Start date: 2012-12-17
Primary completion: 2015-08-31
Enrollment: 503

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.